CME Group Inc. (NASDAQ:CME) insider Kimberly S. Taylor sold 2,300 shares of CME Group stock in a transaction on Thursday, September 29th. The shares were sold at an average price of $106.01, for a total value of $243,823.00. Following the transaction, the insider now owns 105,558 shares of the company’s stock, valued at approximately $11,190,203.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of CME Group Inc. (NASDAQ:CME) opened at 104.52 on Friday. The firm’s 50-day moving average price is $106.83 and its 200 day moving average price is $99.14. CME Group Inc. has a 12-month low of $81.87 and a 12-month high of $110.35. The company has a market cap of $35.42 billion, a price-to-earnings ratio of 26.39 and a beta of 0.85.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The business had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter in the prior year, the company earned $0.95 earnings per share. The company’s revenue was up 10.5% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post $4.44 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date was Wednesday, September 7th. CME Group’s dividend payout ratio is currently 60.61%.
A number of research analysts have issued reports on CME shares. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research note on Monday, June 20th. Credit Agricole SA lowered their price objective on CME Group from $100.00 to $95.00 and set an “underperform” rating for the company in a research note on Thursday, July 14th. Barclays PLC lowered their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a research note on Friday, July 29th. Deutsche Bank AG boosted their price target on CME Group from $110.00 to $111.00 and gave the stock a “buy” rating in a research note on Friday, July 29th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a research note on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. CME Group has an average rating of “Hold” and an average target price of $102.89.
Several hedge funds have recently bought and sold shares of the company. FMR LLC raised its stake in CME Group by 86.8% in the second quarter. FMR LLC now owns 6,394,597 shares of the company’s stock worth $622,833,000 after buying an additional 2,971,686 shares in the last quarter. Investec Asset Management LTD increased its position in shares of CME Group by 5,297.7% in the first quarter. Investec Asset Management LTD now owns 1,569,814 shares of the company’s stock worth $150,781,000 after buying an additional 1,540,731 shares during the last quarter. BlackRock Fund Advisors increased its position in shares of CME Group by 13.7% in the first quarter. BlackRock Fund Advisors now owns 8,495,345 shares of the company’s stock worth $815,978,000 after buying an additional 1,021,766 shares during the last quarter. Westfield Capital Management Co. LP purchased a new position in shares of CME Group during the second quarter worth approximately $93,330,000. Finally, Edgewood Management LLC increased its position in shares of CME Group by 20.3% in the second quarter. Edgewood Management LLC now owns 5,482,310 shares of the company’s stock worth $533,977,000 after buying an additional 923,942 shares during the last quarter. 80.29% of the stock is currently owned by institutional investors and hedge funds.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.